Current Pharmacogenomics and Personalized Medicine
Title:Editorial: Questioning the Governance of Pharmacogenomics and Personalized Medicine for Global Health
Volume: 11 Issue: 4
Author(s): Edward S. Dove
Affiliation:
Keywords: Emerging biotechnologies, global health, governance, knowledge-based innovation, personalized medicine, pharmacogenomics.
Export Options
About this article
Cite this article as:
Dove S. Edward, Editorial: Questioning the Governance of Pharmacogenomics and Personalized Medicine for Global Health, Current Pharmacogenomics and Personalized Medicine 2013; 11 (4) . https://dx.doi.org/10.2174/1875692111999131125160410
DOI https://dx.doi.org/10.2174/1875692111999131125160410 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Personality and Genetics
Current Psychiatry Reviews Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets Induced Pluripotent Stem Cells for the Treatment of Stroke: The Potential and the Pitfalls
Current Stem Cell Research & Therapy Regulation of Glycolytic and Mitochondrial Metabolism by Ras
Current Pharmaceutical Biotechnology Editorial (Thematic Selection: Special Issue on Metabotropic Glutamate Receptors)
Current Neuropharmacology Nonfatal Suicidal Overdose of Olanzapine in an Adolescent
Current Drug Safety New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury
Current Drug Targets Dabigatran Etexilate Reduces Thrombin-Induced Inflammation and Thrombus Formation in Experimental Ischemic Stroke
Current Neurovascular Research Tianeptine: An Antidepressant with Memory-Protective Properties
Current Neuropharmacology Commentary [ Research Highlights(To miR or Not to miR: That is the Question in ALS Disease ]
CNS & Neurological Disorders - Drug Targets The Role of Minocycline in Ischemia-Reperfusion Injury: A Comprehensive Review of an Old Drug with New Implications
Recent Patents on Cardiovascular Drug Discovery A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders
Recent Patents on Food, Nutrition & Agriculture Tachykinins and their Receptors in Human Malignancies
Current Drug Targets Antimicrobial Evaluation of Erythrinan Alkaloids from Erythrina cristagalli L.
Medicinal Chemistry Controlling Shape and Size of TiO2 Nanoparticles with Sodium Acetate
Current Nanoscience beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality?
Mini-Reviews in Medicinal Chemistry “SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain
Current Neurovascular Research Therapeutic Modulation of Growth Factors and Cytokines in Regenerative Medicine
Current Pharmaceutical Design Neurodegenerative Pathways in Parkinsons Disease: Therapeutic Strategies
Current Drug Targets - CNS & Neurological Disorders Biocatalysis in the Pharmaceutical Industry. A Greener Future
Current Green Chemistry